Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: Outcome following anticoagulation

Rheumatology

Volumn 44, Issue 3, 2005, Pages 372-377

  Sangle, Shirish R ^a   D'Cruz, D P ^a   Abbs, I C ^a   Khamashta, M A ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Antiphospholipid antibodies; Antiphospholipid syndrome; Renal artery stenosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CREATININE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; ANGIOPLASTY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMAGING SYSTEM; INTERNATIONAL NORMALIZED RATIO; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; SCLERODERMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS;

ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD PRESSURE; CREATININE; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 14944339194     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh490     Document Type: Article

References (25)

1. Safian RD, Textor SC. Renal artery stenosis. N Engl J Med 2001;344:431-42.
2. Venkatesan J, Henrich W. Ischaemic renal disease. In: Seldin D, ed. The kidney, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2000;2437-56.
3. Sangle S, D'Cruz D, Wajanat J et al. Renal artery stenosis in antiphospholipid syndrome and hypertension. Ann Rheum Dis 2003;62:999-1002.
4. Hughes G. Connective tissue diseases and the skin. The 1983 Prosser-White Oration. Clin Exp Dermatol 1984;9:535-44.
5. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
8. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998;31:181-8.
9. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chamaya K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002;346:1954-62.
10. Perazella MA, Setaro JF. Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders. J Nucl Cardiol 2003;10:184-96.
11. Scoble JE, de Takats D, Ostermann ME et al. Lipid profiles in patients with atherosclerotic renal artery stenosis. Nephron 1999;83:117-21.
12. Bacha J, Aboud E, Correges JP. Prevalence and aspects of arteriopathies in non-insulin dependent diabetes mellitus with severe hypertension. Arch Mal Coeur Vaiss 1997;90:1065-9.
13. Courreges JP, Bacha J, Aboud E, Andre L, Lamacra R. Renal artery stenosis and chronic renal failure in NIDDM. Arch Mal Coeur Vaiss 1998;91:1077-82.
14. Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 1994;32:8-10.
15. Missouris CG, Buckenham T, Coppuccio FC et al. Renal artery stenosis: a common and important problem with peripheral vascular disease. Am J Med 1994;96:10-4.
16. Tegtmeyer CJ, Elson J, Glass TA et al. Percutaneous transluminal angioplasty: The treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology 1982;143:631-7.
17. George J, Shoenfeld Y. The antiphospholipid 'Hughes' syndrome: a cross roads of autoimmunity and atherosclerosis. Lupus 1997;6: 559-60.
18. Harats D, George J, Levy Y, Khamashta MA, Hughes GR, Shoenfeld Y. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. QJM 1999;92:57-9.
19. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho KND, Palosuo T. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;ii:923-5.
20. Palareti G, Leali N, Cocheti S et al. Bleeding complication of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) (Italian Study of Complications of Oral Anticoagulant Therapy). Lancet 1996;348:423-8.
21. Al-Sayegh FA, Ensworth S, Huang S, Stein HB, Kinkoff AV. Haemorrhagic complications of long term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome. J Rheumatol 1997;24:1716-8.
22. Piette JC, Cacoub P. Antiphospholipid syndrome in the elderly: caution. Circulation 1998;97:2195-6.
23. Remondino GI, Mysler E, Pissano MN et al. A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome. Lupus 2000;9:65-7.
24. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GRV. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome. Arch Intern Med 2002;162:1164-9.
25. Sangle S, D'Cruz D, Khamashta MA, Hughes GRV. Renal artery stenosis in hypertensive patients with antiphospholipid syndrome: the effect of anticoagulation. Arthritis Rheum 2003;43:S359.